Drugs / HA115
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03567694 | Oct 2021 → Oct 2022 | asthma | Conjupro Biotherapeutics, Inc. | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HA115 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03567694 ↗ |
| Route | Oral | “administered orally” NCT03567694 ↗ |